. . . . . . . . . . . . "a(CHEBI:erlotinib) -> r(HGNC:COL1A1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Supplemental table: Genes changed in one EGFR+ tumor with erlotinib treatment. To identify significantly changed genes in one pair of EGFR-positive tumors, each probe set on post-therapy array (11 probes per probe set) was compared with the corresponding one of pre-therapy array using Wilcoxon's signed rank test. It was considered to be statistically significant if P < 0.003 for increase or P > 0.997 for decrease (Affymetrix Microarray Suite 5.0 Comparison Analysis). " . . "Selventa" . . . . "2014-07-03T14:32:49.940+02:00"^^ . . .